Bortezomib and BEAM conditioning regimen for upfront autologous stem cell transplantation in mantle cell lymphoma

被引：0
|
作者：
Huynh, A. [1 ]
Roussel, M. [1 ]
Ysebaert, L. [1 ]
Recher, C. [1 ]
Huguet, F. [1 ]
Nouvel, C. [1 ]
Laurent, G. [1 ]
Attal, M. [1 ]
机构：
[1] CHU Purpan, Toulouse, France
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S242 / S242
页数：1
相关论文
共 50 条
  • [1] BORTEZOMIB AND BEAM CONDITIONING REGIMEN FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN MANTLE CELL LYMPHOMA
    Hebraud, B.
    Roussel, M.
    Ysebaert, L.
    Gaudin, C.
    Laurent, G.
    Attal, M.
    Huynh, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 462 - 463
  • [2] Modified BEAM as a conditioning regimen for mantle cell lymphoma patients undergoing autologous hematopoietic stem cell transplantation
    Galieni, Piero
    Falcioni, Sadia
    Troiani, Emanuela
    Picardi, Paola
    Bigazzi, Catia
    Maravalle, Denise
    De Giorgi, Federica
    Taborro, Roberta
    Angelini, Stefano
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
  • [3] Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation
    Galieni, P.
    Troiani, E.
    Bigazzi, C.
    Mazzotta, S.
    Ruggieri, M.
    Pezzoni, V.
    Dalsass, A.
    Mestichelli, F.
    Caraffa, P.
    Travaglini, F.
    Ferretti, S.
    Angelini, M.
    Angelini, S.
    Falcioni, S.
    BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 91 - 93
  • [4] Modified BEAM as conditioning regimen for lymphoma patients undergoing autologous hematopoietic stem cell transplantation
    P Galieni
    E Troiani
    C Bigazzi
    S Mazzotta
    M Ruggieri
    V Pezzoni
    A Dalsass
    F Mestichelli
    P Caraffa
    F Travaglini
    S Ferretti
    M Angelini
    S Angelini
    S Falcioni
    Bone Marrow Transplantation, 2018, 53 : 91 - 93
  • [5] Comparison of Beam and Team as Conditioning Regimen for Lymphoma Patients undergoing Autologous Stem Cell Transplantation
    Atesoglu, Elif Birtas
    Deveci, Burak
    Dora, Imran
    Eren, Cigdem
    Celik, Suat
    Kusdemir, Gokhan
    Bayrak, Esra
    Karadogan, Ihsan
    Gulbas, Zafer
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 302 - 302
  • [6] The impact of socioeconomic disparities on the use of upfront autologous stem cell transplantation for mantle cell lymphoma
    Sawalha, Yazeed
    Radivoyevitch, Tomas
    Jia, Xuefei
    Tullio, Katherine
    Dean, Robert M.
    Pohlman, Brad
    Hill, Brian T.
    Kalaycio, Matt
    Majhail, Navneet S.
    Jagadeesh, Deepa
    LEUKEMIA & LYMPHOMA, 2022, 63 (02) : 335 - 343
  • [7] Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL
    Jiexian Ma
    Shunrong Sun
    Yingwei Hu
    Min Wu
    Lin Shen
    Wulipan Fulati
    Zilan Huang
    Wensi Qian
    Pingping Chen
    Mingyue Chen
    Yanhui Xie
    Bone Marrow Transplantation, 2022, 57 : 1612 - 1614
  • [8] Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL
    Ma, Jiexian
    Sun, Shunrong
    Hu, Yingwei
    Wu, Min
    Shen, Lin
    Fulati, Wulipan
    Huang, Zilan
    Qian, Wensi
    Chen, Pingping
    Chen, Mingyue
    Xie, Yanhui
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1612 - 1614
  • [9] Autologous stem cell transplantation and rituximab for mantle cell lymphoma
    Capote, F.
    Gonzalez-Barca, E.
    Bergua, J.
    Calvo, J. Fernandez
    Oriol, A.
    Garcia-Boyero, R.
    Ramirez, M.
    Caballero, D.
    Romero, A.
    Perez, E.
    Queizan, J.
    Pascual, M.
    Cantalapiedra, A.
    Giraldo, P.
    Palomera, L.
    Guinot, M.
    Ribera, J.
    Leon, A.
    Gil, J.
    Fernandez-Sevilla, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [10] Autologous stem cell transplantation in patients with mantle cell lymphoma
    Oinonen, R
    Jantunen, E
    Itälä, M
    Lehtinen, T
    Kuittinen, O
    Franssila, K
    Wiklund, T
    Elonen, E
    LEUKEMIA & LYMPHOMA, 2002, 43 (06) : 1229 - 1237
12345